Analyst consensus rating
Pliant Therapeutics Analyst Rating: none
Direct answer
Pliant Therapeutics's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $2.00.
Forecast evidence checked October 19, 2026.
Get free Pliant Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.90
- Average price target
- $2.00
- High price target
- $2.00
- Low price target
- $2.00
- Low target gap
- +122.2%
- Target upside
- +122.2%
- High target gap
- +122.2%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Pliant Therapeutics?
Pliant Therapeutics has a verified none consensus. The same dataset has an average price target of $2.00.
How far are Pliant Therapeutics's low and high targets from the recorded price?
The low target implies +122.2%, while the high target implies +122.2%.
How many analysts are included in Pliant Therapeutics's consensus?
The verified consensus includes 1 analysts.
How is Pliant Therapeutics's target upside or downside calculated?
The average target of $2.00 is divided by the recorded price of $0.90, then one is subtracted to produce +122.2%. This does not guarantee a future return.
When was Pliant Therapeutics's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.